Peptide-based amyloid-beta aggregation inhibitors
RSC Medicinal Chemistry · 2025 · 16 (3) · 1083-1104
DOI: 10.1039/d4md00729h ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Naina Sehra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Sector 67, S. A. S. Nagar Punjab 160062 India rahuljai…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Council of Scientific and Industrial Research, India, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
This review delves into the advancements in peptide-based candidates as potential treatment and management options for Alzheimer's disease.
Autor:innen und Institutionen
- Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research Sector 67, S. A. S. Nagar Punjab 160062 India rahuljain@niper.ac.in.
ORCID-Profile: Rahul Jain
Förderung
- Council of Scientific and Industrial Research, India
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Sehra, N., Parmar, R., & Jain, R. (2025). Peptide-based amyloid-beta aggregation inhibitors. RSC Medicinal Chemistry, 16(3), 1083-1104. https://doi.org/10.1039/d4md00729h
Vancouver
Sehra N, Parmar R, Jain R. Peptide-based amyloid-beta aggregation inhibitors. RSC Medicinal Chemistry. 2025;16(3):1083-1104. doi:10.1039/d4md00729h
BibTeX
@article{Sehra2025,
author = {Sehra, Naina and Parmar, Rajesh and Jain, Rahul},
title = {Peptide-based amyloid-beta aggregation inhibitors},
journal = {RSC Medicinal Chemistry},
year = {2025},
volume = {16},
number = {3},
pages = {1083--1104},
doi = {10.1039/d4md00729h}
}
EUVIMED